Thank you to these award-winning poster, podium, and video abstract teams for presenting their studies that will help change the day-to-day practice of urology.
| Presenting Author | Abstract |
|---|---|
| Aurora Grutman | HF02-03: Great Expectations: A Brief History of Women Residents at the Brady Urological Institute at Johns Hopkins Medicine, 1980-2022 |
| Jiping Zeng | MP01-14: Retroperitoneal nodal distribution of metastatic seminoma: a clinical mapping study |
| Rebecca Howland | MP02-13: No Pager No Problems? Analysis of Clinical Messages Received by Urology Residents |
| Philip Olson | MP03-05: Development, Implementation, and Impact of an Electronic Medical Record Alert System for Implanted Artificial Urinary Sphincters |
| Alex Chartier | MP04-02: Ureteroscopic Techniques and Anatomic Sites Associated with Periods of Elevated Intrarenal Pressure |
| Md. Mahmudul Hasan Akash | MP05-14: Neutrophil-derived extracellular vesicles function as mediators of inflammation and bladder toxicities in prostate cancer patients undergoing radiotherapy |
| Guanqun Li | MP06-03: Efficacy of Endoscopic Urethral Stricture Treatment Using Lighted Catheter: an Animal Pilot Trial |
| Shady Saikali | MP07-02: Detection of Prostate Cancer Extracapsular Extension with MRI Using Deep Learning Methods |
| Eiftu Haile | MP08-12: Sarcopenia Predicts Neoadjuvant Chemotherapy Tolerance and Associated Renal Toxicity in Muscle Invasive Bladder Cancer Patients with Borderline Renal Function |
| Leslie Claire Licari | MP09-05: Postoperative Urinary Incontinence Following BPH Surgery: Insights From A Comprehensive U.S. Database Analysis |
| Mark Dawidek | MP10-07: Comprehensive Evaluation of Response to Immune Checkpoint Blockade in Primary Tumor: Radiographic and Radiomic Features Predict Pathologic |
| Sophia Friedl | MP11-09: Incidence of sexually transmitted infections post-gender affirming vaginoplasty |
| Girish Kulkarni | MP12-09: Quality of life and health state utilities in bladder cancer patients across the care trajectory |
| Devon Langston | MP13-08: Fertility Outcomes Across the Rural-Urban Continuum |
| Francesco Barletta | MP14-18: Oncological Outcomes of pN1 Prostate Cancer Patients Treated with Radical Prostatectomy: Does Molecular Imaging Have a Prognostic Impact? Results of a Large, Multi-Institutional Series |
| Nakanori Fujii | MP15-12: Exosome-derived lncRNA MAFG-AS1 predicts the clinical response to pembrolizumab in advanced urothelial carcinoma patients. |
| Bernard Bochner | MP16-17: Phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG) |
| Katherine Wu | MP17-08: Program Directors' Selection Criteria for Urology Residency Match in a USMLE Step 1 Pass/Fail Era |
| Marcelo Bigarella | MP18-18: IMPACT OF 18F-DCFPYL PSMA PET ON ACCURACY of mpMRI IN MEN WITH LOW AND INTERMEDIATE RISK PROSTATE CANCER: INTERIM ANALYSIS OF A PHASE II DIAGNOSTIC TRIAL |
| Daniele Robesti | MP19-15: The significant added value of concomitant systematic prostate biopsies in addition to targeted sampling in patients with previous negative biopsies. Implications for accurate staging predictions from a large multi-institutional series. |
| Mohamad Baker Berjaoui | MP20-01: WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates |
| Than Kyaw | MP21-01: Prenatal care utilization for fetuses with spina bifida in California |
| Benedikt Ebner | MP22-12: Prospective evaluation of objective vs. subjective grading of complications after radical cystectomy |
| Zoe Gan | MP23-09: Pathophysiologic Mechanisms of Urinary Incontinence in Nulliparous Female Elite Athletes: A Cross-Sectional Study Using Dynamic Pelvic Magnetic Resonance Imaging |
| Sunny Nalavenkata | MP24-07: Presenting information in prostate cancer screening decision aids: more information or the bottom-line gist? A randomized controlled trial |
| Jenna Winebaum | MP25-11: Real-World Comparison of utility of PSMA PET imaging and MRI in evaluation of laterality of prostate cancer |
| Connor Forbes | MP26-01: Prospective observational cohort study comparing surgical intervention versus observation for nephrolithiasis and history of urinary tract infections: an interim analysis from the EDGE Consortium |
| Roseanne Ferreira | MP27-17: Effectiveness of Rezūm for catheter-dependent urinary retention: 12 months outcomes of a Real-world database |
| Garrett Brinkley | MP28-14: Novel in vivo Peyronie’s patient-derived xenograft model recapitulates human curvature in immunocompromised rats |
| MP29 | |
| Andrei Cumpanas | MP30-11: Immersive Virtual Reality for Percutaneous Nephrolithotomy (PCNL): "The More You Know, the Safer and More Effective the Outcome" |
| Samuel Tate | MP31-14: PREDICTORS OF CLINICALLY SIGNIFICANT PROSTATE CANCER AMONGST AFRICAN AMERICAN MEN WITH PI-RADS 3 INDEX LESION UNDERGOING MRI-TARGETED BIOPSY |
| Guanqun Li | MP32-18: Role of Hypogonadism in Urethral Stricture Formation in Rabbit Urethral Stricture Model |
| Ghizlane Moussaoui | MP33-19: A Transfusion Dashboard initiative safely reduces unnecessary group and screen testing for endourologic procedures |
| Shanice Cox | MP34-04: A Framework for Evaluating Health Disparities in Adult Neurogenic Lower Urinary Tract Dysfunction - Systematic Review and Neurogenic Bladder Research Group Workshop Recommendations |
| Hersh Trivedi | MP35-15: Efficacy of inpatient, evidence-based tobacco use treatment of patients with bladder cancer after radical cystectomy |
| Margaret Meagher | MP36-19: Development and validation of a novel nomogram to predict lymph node invasion in upper tract urothelial carcinoma |
| MP37 | |
| Saad Sabbagh | MP38-11: Sociodemographic Factors Predictive of Lymph Node Dissection Performance in Patients with Upper Tract Urothelial Carcinomas |
| Jeffrey Ellis | MP39-14: Evaluating the Contribution of the Standardized Letter of Recommendation to a Successful Match in Urology Residency |
| Jonathan Ellison | MP40-06: A Patient-Prioritized Agenda for Comparative Effectiveness Trials in Kidney Stone Disease |
| Shiv Verma | MP41-20: Potential biomarkers for cognitive impairment associated with androgen deprivation |
| Gabi Shokaier | MP42-05: Effect of Varicocele Repair on Pregnancy and Live Birth Rates in Severe Oligospermic patients undergoing Assisted Reproductive Technology |
| William Azar | MP43-06: Is It Time to Abandon the Transrectal Probe in Prostate Biopsy? |
| Carlos Munoz-Lopez | MP44-05: Parenchymal Volume Analysis to Assess Longitudinal Functional Decline and Atrophy After PN |
| Kim Maciolek | MP45-02: Evaluation of an Automated CT-Based Deep Learning Image Segmentation Model for Stone Characterization in Difficult-to-Image Situations |
| Sai Allu | MP46-15: A quality improvement initiative improved antibiotic stewardship for patients undergoing bladder outlet surgery |
| Nicholas Deebel | MP47-10: Seeing Vasectomy Through a Different Lens: Utilizing Virtual Reality to Enhance Vasectomy Comfort and Reduce Anxiety in Single-Center, Randomized, Open-Label Clinical Trial |
| Kourosh Kalayeh | MP48-04: Role of contrast enhanced ultrasound in evaluating obstruction resolution after pyeloplasty |
| Ryan Fogg | MP49-16: Creation of an Age-Based Nomogram for PSA Values in the Spinal Cord Injury Population |
| Katherine Chan | MP50-10: Ask the patients: development of an adolescent and young adult patient-reported outcomes measure for hypospadias care |
| Jesse Spooner | MP51-17: Natural history of patients with regional lymph node positive renal cell carcinoma: Results from the Canadian Kidney Cancer Collaboration |
| Muhammed A Moukhtar Hammad | MP52-13: Retrospective Concomitant Nonrandomized Comparison of Testosterone Replacement Therapy Versus No Treatment for Erectile Function Post Radical Prostatectomy |
| Arjun Pon Avudaiappan | MP53-11: Neoadjuvant chemotherapy with radical cystectomy in muscle-invasive bladder cancer: Evaluating the pathological response and survival outcomes in octogenarians |
| Juan Carlos Castaño Botero | MP54-15: Breaking Barriers in Urology: Enhancing Surgical Accessibility for Paraplegic Urologists and Promoting Inclusivity |
| Diane Aponte-Colon | MP55-07: PEDIATRIC AND YOUNG ADULT UROTHELIAL CANCER CLINICOPATHOLOGIC AND SURVIVAL OUTCOMES: A SYSTEMATIC REVIEW |
| Victor Sandoval | MP56-03: Oncological Outcomes for T1 Small Renal Cell Carcinoma After Partial Nephrectomy is not significantly associated with histopathological subtype: A 20-Year Retrospective Follow up From One Single Institution |
| Cecilia Wada | MP57-05: Integrated care within a large public healthcare system improves efficiency and reduces costs associated with kidney stone management |
| Anael Rizzo | MP58-18: Does Equal Access mean Equal Access to Secondary Treatments after Biochemical Recurrence (BCR) following Radical Prostatectomy (RP) |
| Hiroshi Shimura | MP59-04: Micturition-related neural activity in the cerebral cortex depends on the location, cell-type, and projection pathway uncovered by two-photon calcium imaging |
| Aldo Brassetti | MP60-19: Oncological outcomes of low volume CRPC: results from a longitudinal real-life multicenter cohort |
| Nathan Lawrentschuk | MP61-02: Snap diagnosis: pilot study of AI-powered smartphone application for penile cancer detection from the comfort of your home |
| Perry Xu | MP62-12: Waiting for HoLEP – Outcomes when Complications Arise in the Preoperative Period |
| Anne Hong | MP63-11: Raised intrarenal pressures lead to bacteraemia |
| Marietherese Valovska | MP64-01: Genitourinary and Sexual Wellbeing-Related Patient Reported Outcome Measures Used in Gender-Affirming Care: An Analysis of Readability, Comprehensiveness and Appropriateness |
| Padraic O'Malley | MP65-19: Therapy of advanced bladder cancer by targeting Hyal2 with antibody-drug conjugate: Preclinical study |
| Karen Hannigan | MP66-07: Atypical smooth muscle cells in the mouse corpus cavernosum express key neurotransmission pathway genes |
| Genesis Dolgetta | MP67-10: 15-Year Follow-Up of Oncologic and Renal Function Outcomes: Radiofrequency Ablation of Renal Tumors 3-7 cm using Fiberoptic, Non-Conducting Temperature Monitoring |
| Maheetha Bharadwaj | MP68-06: Investigating the Connection between Historical Slavery, Social Determinants of Health, and Prostate Cancer Incidence (2018) by Race—A County-Level Analysis |
| Daniel Massana Roquero | MP69-05: Developing an Antimicrobial Irrigation Solution for Endourological Procedures: Ex Vivo Efficacy and In Vivo Safety |
| Yaw Nyame | MP70-10: Drivers and barriers to accessing prostate specific antigen screening for early detection of prostate cancer among Black men |
| William Shi | MP71-19: Ultrasensitive urinary liquid biopsy analysis for BCG response assessment in high-risk non-muscle invasive bladder cancer |
| Carol Davis Dao | MP72-06: Predictors of Risk of Subsequent Urinary Tract Infection in a Multicenter Cohort of Patients with Primary Vesicoureteral Reflux: Preliminary Insights on Risk Prediction |
| Lauren Shepard | MP73-05: A hydrogel transperineal benchtop prostate biopsy simulator with a built-in real-time quantitative assessment of biopsy accuracy |
| Dimple Chakravarty | MP74-10: AI-based risk-stratification tool PATHOMIQ_PRAD analyzes histopathology images to accurately predict metastasis in black men and helps discover cancer drivers |
| Thomas Monaghan | MP75-10: Nocturia across the heart failure continuum: results from an outpatient urology population |
| Brian Im | MP76-14: Prophylactic Dips and Irrigation Solutions Can Considerably Alter the Antimicrobial Efficacy of Inflatable Penile Prosthesis Hydrophilic Surface Coatings |
| Leilei Xia | MP77-10: Residual cancer at radical cystectomy with or without neoadjuvant chemotherapy for clinical T2 muscle-invasive bladder cancer: a pathologic stage-matched comparison |
| Braulio Manzo | MP78-16: Prospective Randomized Controlled Trial of Trilogy vs Holmium High Power Laser Lithotripsy for Kidney Stones GUY's 1 & 2 in MiniPCNL (TriHolmium Trial) |
| Rebecca Arteaga | V01-01: Robotic ureteral reconstruction of non-absorbable clip erosion into the ureter: a case series |
| Patrick Saba | V02-01: Design and Development of a High-Fidelity Hydrogel Simulation Model for Artificial Urinary Sphincter Placement Utilizing Expert Consensus |
| Bingyuan Yang | V03-01: How effective is ureteroscopic irrigation at evacuating stone dust? |
| Wei Zheng So | V04-01: Artificial Intelligence (AI) Generated Patient Information Videos (PIVs) for Partial Nephrectomy by Medical Students with Expert Validation - A Pilot Study |
| Annaliese Ionson | V05-01: Pediatric Single-port, Robotic, Transvesical Vesicovaginal Fistula Repair |
| Jirong Lu | V06-01: Approach to splitting a donor horseshoe kidney for transplantation |
| Julio Yanes | V07-02: Enhancing Urology Resident Training in Vasectomies Through a 3D Printed Simulation Model |
| Alessandro Marquis | V08-04: Robotic Radical Cystectomy and Right Renal Graft Nephroureterectomy for Urothelial Carcinoma in a Double Renal Transplant Recipient |
| Alejandro Bautista-Perez-Gavilan | V09-01: Updated Experience on Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Testicular Cancer |
| Amr A Elbakry | V10-05: Synergizing Solutions: Bladder Mucosa Graft Urethroplasty in Concurrent Management of Urethral Stricture and Bladder/Prostate Conditions |
| Kendrick Campbell | V11-01: Tutorial and Case Series: Urethral Paclitaxel-Coated Balloon Dilation |
| Marco Martiriggiano | V12-07: Near-infrared fluorescence imaging with indocyanine green: a novel intra-operative tool for the management of massive lymphorrhea after robot-assisted radical prostatectomy |
| Alysen Demzik | V13-01: Catheterizable Channels with Bladder Augmentation: An Intra-operative Decision Making Algorithm Stratified by Neurogenic Bladder Phenotypes |
| Luca Morgantini | V14-05: Artificial Intelligence-Based Intraoperative Guidance: Demonstration of Real-Time Segmentation and Feature Tracking in Robotic Surgery |
